Literature DB >> 2994716

Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).

S Yoshitake, B G Schach, D C Foster, E W Davie, K Kurachi.   

Abstract

Two different human genomic DNA libraries were screened for the gene for blood coagulation factor IX by employing a cDNA for the human protein as a hybridization probe. Five overlapping lambda phages were identified that contained the gene for factor IX. The complete DNA sequence of about 38 kilobases for the gene and the adjacent 5' and 3' flanking regions was established by the dideoxy chain termination and chemical degradation methods. The gene contained about 33.5 kilobases of DNA, including seven introns and eight exons within the coding and 3' noncoding regions of the gene. The eight exons code for a prepro leader sequence and 415 amino acids that make up the mature protein circulating in plasma. The intervening sequences range in size from 188 to 9473 nucleotides and contain four Alu repetitive sequences, including one in intron A and three in intron F. A fifth Alu repetitive sequence was found immediately flanking the 3' end of the gene. A 50 base pair insert in intron A was found in a clone from one of the genomic libraries but was absent in clones from the other library. Intron A as well as the 3' noncoding region of the gene also contained alternating purine-pyrimidine sequences that provide potential left-handed helical DNA or Z-DNA structures for the gene. KpnI repetitive sequences were identified in intron D and the region flanking the 5' end of the gene. The 5' flanking region also contained a 1.9-kb HindIII subfamily repeat. The seven introns in the gene for factor IX were located in essentially the same position as the seven introns in the gene for human protein C, while the first three were found in positions identical with those in the gene for human prothrombin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994716     DOI: 10.1021/bi00335a049

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  153 in total

1.  Discrete mobility of single-stranded DNA in non-denaturing gel electrophoresis.

Authors:  Q Liu; W A Scaringe; S S Sommer
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP.

Authors:  G Sarkar; H S Yoon; S S Sommer
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  PRE: a novel element with the hallmarks of a retrotransposon derived from an unknown structural RNA.

Authors:  D O Ricke; R P Ketterling; S S Sommer
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

4.  Screening for mutations in the gene encoding factor IX.

Authors:  L R Nielsen; M Schwartz; E Scheibel
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

5.  A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model.

Authors:  F Giannelli; S Saad; A J Montandon; D R Bentley; P M Green
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

6.  Double-stranded DNA segments can efficiently prime the amplification of human genomic DNA.

Authors:  G Sarkar; S S Sommer
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

7.  Prototypic sequences for human repetitive DNA.

Authors:  J Jurka; J Walichiewicz; A Milosavljevic
Journal:  J Mol Evol       Date:  1992-10       Impact factor: 2.395

8.  A rapid test for V(D)J recombinase activity.

Authors:  S Kallenbach; M Goodhardt; F Rougeon
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

9.  Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.

Authors:  E Leitersdorf; H H Hobbs; A M Fourie; M Jacobs; D R van der Westhuyzen; G A Coetzee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.

Authors:  Claudia Pamela Radic; Liliana Carmen Rossetti; Miguel Martín Abelleyro; Miguel Candela; Raúl Pérez Bianco; Miguel de Tezanos Pinto; Irene Beatriz Larripa; Anne Goodeve; Carlos Daniel De Brasi
Journal:  Thromb Haemost       Date:  2012-10-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.